1 domain / 1 area / 1 specialization
ADAR1 Capital Management
Also known as: ADAR1, ADAR1 Capital Management, LLC
Data updated
ADAR1 Capital Management is an Austin-based investment manager focused on public and private equity investments in life sciences and biotechnology. Public adviser and investor materials point to a specialist healthcare and biotech orientation.
ADAR1's relevance to psychedelic medicine is source-backed through atai's 2025 private placement. The record is useful for mapping public-market and crossover healthcare capital around psychedelic mental-health drug development.
Investor Context
Institutional InvestorsInvestment Context
This stakeholder is listed as an Institutional Investor within Institutional Investors. Its public geography context is global. Public stage signals include Public Markets and Growth / Late Stage. Public focus areas include Drug Development.
Public Portfolio Examples
- atai Life SciencesPrivate placement financing - approximately $50 million - Jul 1, 2025
- AtaiBeckleyPortfolio stakeholder
ADAR1 Capital Management is included as a life-science and biotechnology investment manager with a confirmed atai financing record. It should be understood as healthcare/public-market capital with psychedelic-adjacent exposure through atai rather than a dedicated psychedelics fund.
Investor Type
Institutional Investor
Geographic Scope
Global
Psychedelic Focus
Psychedelic-Adjacent Focus
Engagement
Active
Investment Stage Focus
Investment Focus Areas
Portfolio Stakeholders
Recorded Investments
Jul 1, 2025
Private placement financing - approximately $50 million
Direct atai participation; clear source-backed psychedelic therapeutics relevance.
atai Life Sciences Announces $50 Million Private Placement FinancingQuick Facts
- Founded
- 2019
- HQ
- Austin, Texas, United States
- Website
- Visit